Advanced Micro Devices INC ADVANC.../ US0079031078 /
2024-05-24 7:22:46 PM | Chg. - | Volume | Bid8:56:31 AM | Ask8:56:31 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
164.31USD | - | 284,511 Turnover: 1.49 mill. |
151.46Bid Size: 5,000 | 167.40Ask Size: 5,000 | 256.93 bill.USD | - | 299.92 |
GlobeNewswire
8:55 AM
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire
3:13 AM
Opthea Announces Placement and Partially Underwritten Entitlement Offer to Raise up to Approximately...
GlobeNewswire
06-11
Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer an...
GlobeNewswire
06-10
SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...
GlobeNewswire
06-08
4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion C...
GlobeNewswire
06-05
YieldMax™ ETFs Announces Monthly Distributions on MSTY (106.33%), NVDY (101.82%), CONY (84.85%), YBI...
GlobeNewswire
06-04
Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
06-03
AMD Accelerates Pace of Data Center AI Innovation and Leadership with Expanded AMD Instinct GPU Road...
GlobeNewswire
06-03
AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen a...
GlobeNewswire
05-28
AMD Chair and Chief Executive Officer Dr. Lisa Su to Deliver the Opening Keynote at Computex 2024
GlobeNewswire
05-28
Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizuma...
GlobeNewswire
05-28
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD